About 7,238 results

ALLMedicine™ Platelet Aggregation Center

Research & Reviews  2,548 results

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entitie...
Blood Advances; Aiello S, Gastoldi S et. al.

Dec 2nd, 2021 - Unrestrained activation of the complement system till the terminal products, C5a and C5b-9, plays a pathogenetic role in acute and chronic inflammatory diseases. In endothelial cells, complement hyperactivation may translate into cell dysfunction,...

Impact of frozen thawed embryo transfer in hormone substituted cycles on thrombotic ris...
Thrombosis Research; Dalsgaard TH, Hvas AM et. al.

Dec 1st, 2021 - Fertility treatment with frozen thawed embryo transfer (FET) is widely used. Women treated in artificial cycles (AC-FET) receive high doses of estrogen in contrast to natural cycles (NC-FET), where no estrogen is administered. Estrogen substitutio...

DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Molecular Medicine (Cambridge, Mass.); Lin J, Zeng J et. al.

Nov 29th, 2021 - Thrombocytopenia is one of the most common hematological disease that can be life-threatening caused by bleeding complications. However, the treatment options for thrombocytopenia remain limited. In this study, giemsa staining, phalloidin staining...

European Journal of Pharmacology - Regular article the antiplatelet effect of mirtazapi...
European Journal of Pharmacology; Kawano Y, Obana M et. al.

Nov 25th, 2021 - Mirtazapine (MTZ) is a noradrenergic and specific serotonergic antidepressant that has been associated with an increased risk of bleeding. However, there is insufficient evidence confirming this association. We hypothesised that 5-HT2A and α2 rece...

Sex-specific platelet activation through protease-activated receptor-1 in patients unde...
Atherosclerosis Gremmel T, Michelson AD et. al.

Nov 23rd, 2021 - Protease-activated receptor (PAR)-1-mediated platelet activation may vary according to sex and clinical situation. In order to investigate sex-specific platelet activation through PAR-1, we assessed platelet response to thrombin receptor-activatin...

see more →

Guidelines  1 results

Prophylaxis and management of venous thromboembolism in patients with myeloproliferativ...
Annals of Hematology; Kreher S, Ochsenreither S et. al.

Oct 14th, 2014 - Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like polycythemia vera and essential thrombocythemia are at increased risk of arterial and venous thrombosis. Strategies of prevention may consist of platelet aggreg...

see more →

Drugs  50 results see all →

Clinicaltrials.gov  145 results

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes

Nov 10th, 2021 - APPEASED is a phase 1 open-label single arm pilot trial, aiming to determine the feasibility of a larger confirmatory randomized trial, and to characterize the prevalence of incomplete platelet inhibition after exposure to EC aspirin at doses of 8...

The Antiaggregation Monitoring (TAM) Registry

Oct 22nd, 2021 - Acetylsalicylic acid (ASA) resistance (R) is best defined as an ineffective inhibition of the platelet cyclooxygenase (COX)-1 pathway, and has been reported in 1 to 61 % of patients treated with ASA. Impaired response to ASA has been associated wi...

The Effects of Topical Treatment With Clonidine + Pentoxifylline in Patients With Neuropathic Pain

Oct 21st, 2021 - Microvascular dysfunction underlies pain in different animal models of neuropathic pain. Pentoxifylline is a phosphodiesterase inhibitor that reduces cyclic adenosine monophosphate (cAMP) hydrolysis, enhances blood flow and reduces platelet aggreg...

MonotherApy of Low-does TicagrElor After Percutaneous Coronary Intervention

Oct 4th, 2021 - Compared with clopidogrel, ticagrelor inhibit platelet aggregation faster and stronger, and significantly reduce the risk of cardiovascular and cerebrovascular adverse events. In recent years, it has been given the strongest recommendation for ant...

MACCE in Hospitalized Patients With Community-acquired Pneumonia

Sep 30th, 2021 - Community-acquired pneumonia (CAP) is the most common infection leading to hospitalization in intensive care units and the most common cause of death associated with infection disease. Epidemiological studies have shown that respiratory tract infe...

see more →

News  151 results

Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
Ted Bosworth

Nov 17th, 2021 - The experimental monoclonal antibody bentracimab, which reverses the antiplatelet effects of ticagrelor, appears to be heading toward regulatory approval, on the basis of an interim analysis of the phase 3 REVERSE-IT trial. Dr.

Self-Injected Antiplatelet for Acute MI Enters Phase 3 Testing

Jun 30th, 2021 - A phase 3 study testing the safety and efficacy of the fast-acting, self-administered P2Y12 receptor antagonist selatogrel (Idorsia Pharmaceuticals) for the treatment of suspected acute myocardial infarction (AMI) is underway, the company has anno...

Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy
Christopher James Little, MD, Bao Sean Nguyen, MD et. al.

May 12th, 2021 - Coronary artery vasospasm is a rare but well-known adverse effect of 5-fluorouracil (5-FU) that can be life threatening if unrecognized. Patients typically present with anginal chest pain and ST elevations on electrocardiogram (ECG) without athero.

Prostacyclin Analogs for the Treatment of PAH

May 12th, 2021 - Key Takeaways: Several prostacyclin and prostaglandin IP receptor agonists have been approved by the US Food and Drug Administration (FDA) for pulmonary arterial hypertension (PAH). These analogs work by promoting direct arterial vasodilation and ...

AZ COVID Vaccine: Causal Link to Severe Thrombosis Established

Apr 12th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two scientific studies establishing a causal relationship between the AstraZeneca COVID-19 vaccine and severe thrombotic complications have now be...

see more →